Breaking News Instant updates and real-time market news.

GKOS

Glaukos

$30.53

(0.00%)

09:22
02/27/18
02/27
09:22
02/27/18
09:22

Glaukos should be bought at current levels, says Piper Jaffray

Glaukos this morning released data published in Clinical Ophthalmology that showed sustain, unmedicated intraocular pressure reduction from single or multiple implants at 36 months for standalone procedures, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst is impressed by iStent's standalone durability, especially of two stents out to 42 months which had 91% of eyes with over 20% reduction in IOP without medication. He believes investors should be building positions in Glaukos shares at these levels. O'Brien has an Overweight rating on the stock with a $35 price target.

  • 28

    Feb

  • 11

    Mar

GKOS Glaukos
$30.53

(0.00%)

12/12/17
WELS
12/12/17
NO CHANGE
Target $42
WELS
Outperform
Reimbursement remains favorable for Glaukos iStent, says Wells Fargo
After Medicare administrative contractors Palmetto and Cahaba posted their 2018 physician fee schedules for Glaukos' iStent and Alcon's CyPass, Wells Fargo analyst Larry Biegelsen notes that the 2018 rates represent a meaningful cut to iStent physician reimbursement versus 2017 rates and signal a potential continued trend of physician reimbursement cuts from the different MACs. Still even at these lower rates iStent procedures remain very profitable, the analyst argues, adding that adoption should not be meaningfully impacted by these cuts. He reiterates an Outperform rating and $42 price target on Glaukos' shares.
12/28/17
WELS
12/28/17
NO CHANGE
WELS
Outperform
Glaukos iStent inject device to reaccelerate growth, says Wells Fargo
Wells Fargo analyst Larry Biegelsen yesterday reiterated his belief that the U.S. launch of iStent inject will reaccelerate Glaukos' top line growth. The company yesterday announced that it has submitted a pre-market approval application to the FDA for the iStent inject Trabecular Micro-Bypass Stent. The analyst currently models for Glaukos worldwide sales growth of 9.2% in 2018, improving to 21.4% in 2019. Based on his channel checks, iStent inject offers clinicians with increased efficacy over the first-generation iStent product and increased ease of use. Biegelsen believes that iStent inject is the easiest of any of the microinvasive glaucoma surgery devices to implant. He keeps an Outperform rating on Glaukos.
12/28/17
CANT
12/28/17
NO CHANGE
Target $48
CANT
Overweight
Glaukos price target lowered to $48 from $60 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros lowered his price target for Glaukos to $48 following a model refresh heading into 2018. The anlayst, however, reiterates an Overweight rating on the shares following the company's iStent Inject device pre-market approval application filing with the FDA. While questions over competition and reimbursement dominated the last few quarters, the headwinds are manageable and investors underappreciate the long-term potential of the iStent franchise, Piros tells investors in a research note.
01/10/18
PIPR
01/10/18
NO CHANGE
Target $35
PIPR
Overweight
Glaukos price not reflecting 'unique franchise' long-term value, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien notes that Glaukos released further iDose data from a cohort of 74 patients that showed sustained reduction through 12 months. The favorable profile of iDose makes it an attractive offering and a valuable pipeline product for the company, the analyst says. For the stock, O'Brien believes there is probably further MAC headline risk in the near-term and he would like to see guidance out of the way before jumping in full force. Nonetheless, the analyst thinks the current stock price does not reflect the long-term value of this "unique franchise." He reiterates an Overweight rating and $35 price target on the shares.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$100.70

-0.69 (-0.68%)

10:05
07/20/18
07/20
10:05
07/20/18
10:05
Options
Lowe's call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:05
07/20/18
07/20
10:05
07/20/18
10:05
General news
Fed's Bullard commented on Trump's policy references: »

Fed's Bullard…

SHOP

Shopify

$173.00

1.32 (0.77%)

, WMT

Walmart

$87.49

-0.24 (-0.27%)

10:03
07/20/18
07/20
10:03
07/20/18
10:03
Periodicals
Walmart acquiring Shopify no longer 'laughable idea,' TechCrunch says 

Reference Link

SHOP

Shopify

$173.00

1.32 (0.77%)

WMT

Walmart

$87.49

-0.24 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

DPLO

Diplomat Pharmacy

$23.05

-1.87 (-7.50%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Diplomat Pharmacy falls -7.4% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCP

TC PipeLines

$32.55

-2.67 (-7.58%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
TC PipeLines falls -8.3% »

TC PipeLines is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SKX

Skechers

$24.62

-8.62 (-25.93%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Skechers falls -25.9% »

Skechers is down -25.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBR

Centrais Electricas

$4.57

0.27 (6.28%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Centrais Electricas rises 6.5% »

Centrais Electricas is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBDO

Banco Bradesco

$6.81

(0.00%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Banco Bradesco rises 7.1% »

Banco Bradesco is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOL

Gol Linhas

$7.18

0.61 (9.28%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Gol Linhas rises 9.3% »

Gol Linhas is up 9.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIT

Wipro

$5.23

0.07 (1.36%)

09:59
07/20/18
07/20
09:59
07/20/18
09:59
Hot Stocks
Breaking Hot Stocks news story on Wipro »

Wipro sees Q2 IT Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

WIT

Wipro

$5.23

0.07 (1.36%)

09:58
07/20/18
07/20
09:58
07/20/18
09:58
Earnings
Wipro reports Q1 EPS 7c, consensus 7c »

Wipro reports Q1 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HON

Honeywell

$151.70

4.13 (2.80%)

09:56
07/20/18
07/20
09:56
07/20/18
09:56
Hot Stocks
Honeywell says proactively managing direct, indirect impacts from tariffs »

Says sales growth was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

MGM

MGM Resorts

$30.64

-0.19 (-0.62%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Hot Stocks
MGM Resorts says 'well-positioned' in Japan »

MGM Resorts International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

BHLB

Berkshire Hills Bancorp

$40.90

-0.05 (-0.12%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Downgrade
Berkshire Hills Bancorp rating change  »

Berkshire Hills…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTAS

Cintas

$202.71

8.92 (4.60%)

, STI

SunTrust

$71.16

2.16 (3.13%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Options
Early notable gainers among liquid option names on July 20th »

Notable gainers among…

CTAS

Cintas

$202.71

8.92 (4.60%)

STI

SunTrust

$71.16

2.16 (3.13%)

COF

Capital One

$98.50

3.18 (3.34%)

VFC

VF Corp.

$91.37

2.16 (2.42%)

SWK

Stanley Black & Decker

$144.21

4.61 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

CTXS

Citrix

$108.80

-0.86 (-0.78%)

09:54
07/20/18
07/20
09:54
07/20/18
09:54
Downgrade
Citrix rating change  »

Citrix cut to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 08

    Aug

09:45
07/20/18
07/20
09:45
07/20/18
09:45
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

CVLT

Commvault

$69.20

(0.00%)

09:44
07/20/18
07/20
09:44
07/20/18
09:44
Hot Stocks
Commvault appoints two new directors following agreement with Elliott »

Commvault last night…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 08

    Aug

FB

Facebook

$208.08

(0.00%)

, GOOGL

Alphabet Class A

$1,199.26

(0.00%)

09:43
07/20/18
07/20
09:43
07/20/18
09:43
Recommendations
Facebook, Alphabet Class A analyst commentary  »

Facebook expected Q2…

FB

Facebook

$208.08

(0.00%)

GOOGL

Alphabet Class A

$1,199.26

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Jul

  • 18

    Sep

HON

Honeywell

$147.57

(0.00%)

, SWKS

Skyworks

$102.46

(0.00%)

09:40
07/20/18
07/20
09:40
07/20/18
09:40
Options
Unusually active option classes on open July 20th »

Unusual total active…

HON

Honeywell

$147.57

(0.00%)

SWKS

Skyworks

$102.46

(0.00%)

EWZ

MSCI Brazil Index

$34.46

(0.00%)

GE

General Electric

$13.73

(0.00%)

NUGT

Direxion Gold Miners Bull

$22.20

(0.00%)

JD

JD.com

$36.87

(0.00%)

SLV

iShares Silver Trust

$14.41

(0.00%)

XLI

Industrial Select Sector SPDR

$74.53

(0.00%)

IBM

IBM

$149.25

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 06

    Aug

  • 14

    Aug

  • 04

    Sep

09:38
07/20/18
07/20
09:38
07/20/18
09:38
General news
Trump trade and rate comments lead to mixed open »

Stock futures fell…

AMZN

Amazon.com

$1,812.85

-29.51 (-1.60%)

09:34
07/20/18
07/20
09:34
07/20/18
09:34
Recommendations
Amazon.com analyst commentary  »

Amazon's AWS to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

SAUC

Diversified Restaurant

$1.22

0.05 (4.27%)

09:33
07/20/18
07/20
09:33
07/20/18
09:33
Syndicate
Diversified Restaurant 6M share Secondary priced at $1.00 »

Dougherty acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLMD

Galmed

$14.99

0.96 (6.84%)

09:31
07/20/18
07/20
09:31
07/20/18
09:31
Initiation
Galmed initiated  »

Galmed initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

09:31
07/20/18
07/20
09:31
07/20/18
09:31
Recommendations
Intuitive Surgical analyst commentary  »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.